M&A Deal Summary |
|
---|---|
Date | 2021-09-20 |
Target | Pulse Scientific |
Sector | Medical Products |
Buyer(s) | KSL Biomedical |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
KSL Biomedical is a translational medicine technology company that develops innovative diagnostic and therapeutic IP impacting immunology, oncology, virology, and genomics. Investing in basic research and licensing for novel technologies to improve patient outcomes, KSL specializes in early diagnosis and companion diagnostics to facilitate effective therapy. KSL Biomedical was founded in 2017 and is based in Buffalo, New York.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Ontario) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2021) | 1 of 1 |